Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with pasireotide and pegvisomant under the National Health Act 1953, section 100 for patients with acromegaly.
Patients must be eligible for the PBS and meet the relevant criteria in the restrictions.
The Schedule of Pharmaceutical Benefits on the PBS website lists restrictions for prescribing pasireotide and pegvisomant.
Section 100 arrangements
pasireotide and pegvisomant
These items are only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending:
- an approved private hospital
- a public hospital.
These items aren’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.
Authority applications
Applying for initial treatment
Please note: You don’t need to complete this application in writing when you request PBS authority online.
Applications for initial authority approval to prescribe PBS-subsidised pasireotide or pegvisomant to treat acromegaly can be made:
- using the Online PBS Authorities system
- in writing and use HPOS Form upload
- in writing and mail to PBS Complex Drugs Programs.
All written applications for pasireotide must include:
- details of the proposed prescription or prescriptions
- the completed acromegaly - pasireotide - initial authority application form
- relevant attachments.
All written applications for pegvisomant must include:
- details of the proposed prescription or prescriptions
- the completed acromegaly - pegvisomant - initial authority application form
- relevant attachments.
Applying for continuing treatment
Applications for continuing authority approval to prescribe PBS-subsidised pasireotide or pegvisomant to treat acromegaly can be made either:
- in real time using the Online PBS Authorities system
- by calling the PBS Complex Drugs Programs enquiry line.
More information
Call the PBS Complex Drugs Programs enquiry line for more information.